| Net Cash Provided by (Used in) Operating Activities |
$21,100,000 |
USD |
96% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$20,648,000 |
USD |
-120% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$3,001,000 |
USD |
22% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
35,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$2,373,000 |
USD |
14% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$495,000 |
USD |
18% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$29,419,000 |
USD |
-13% |
Q4 2025 |
FY 2025 |
| Operating Lease, Liability |
$19,620,000 |
USD |
-1.8% |
Q4 2025 |
FY 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$58,084,000 |
USD |
47% |
Q4 2025 |
FY 2025 |
| Property, Plant and Equipment, Gross |
$371,730,000 |
USD |
3.6% |
Q4 2025 |
FY 2025 |
| Operating Lease, Liability, Current |
$1,350,000 |
USD |
13% |
Q4 2025 |
FY 2025 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.0766 |
pure |
0.52% |
Q4 2025 |
FY 2025 |
| Unrecognized Tax Benefits |
$3,380,000 |
USD |
364% |
Q4 2025 |
FY 2025 |
| Additional Paid in Capital |
$11,456,000 |
USD |
22% |
Q4 2025 |
FY 2025 |
| Depreciation, Depletion and Amortization |
$6,963,000 |
USD |
-1.4% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$28,924,000 |
USD |
-13% |
Q4 2025 |
FY 2025 |
| Interest Expense |
$37,013,000 |
USD |
-8.6% |
Q3 2024 |
Q3 2024 |